ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Low testosterone is a better predictor of mortality than sarcopenia in men with liver disease
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 25308" data-attributes="member: 3"><p>It is so disturbing for me to hear about men who are refused TRT because they have liver disease even though we know that T gels/creams, injections, pellets, etc do not cause liver issues (only old oral testosterone did).</p><p></p><p><strong>Low testosterone is a better predictor of mortality than sarcopenia in men with advanced liver disease</strong></p><p></p><p></p><p>Journal of Gastroenterology and Hepatology, 2015</p><p>pp 1440-1746</p><p></p><p>[h=3]Abstract[/b][h=4]Introduction[/b]Both sarcopenia and low serum testosterone have been associated with increased mortality in men with cirrhosis. It is not known how these variables interact.</p><p></p><p></p><p>[h=4]Methods[/b]We conducted a retrospective longitudinal cohort study of 145 men referred for liver transplant evaluation between 2005 and 2012. Baseline demographics included hormone profile and MELD score. Baseline computerised tomography was reformatted to calculate skeletal muscle area at L4 using validated, Tomovision software-based methodology. The primary outcome was time to death or liver transplantation.</p><p></p><p></p><p>[h=4]Results[/b]Median testosterone was low at 6.2 nmol/L (ref 10–27.6 nmol/L) as was muscle mass at 48.0 cm[SUP]2[/SUP]/m[SUP]2[/SUP] (ref >52.4 cm[SUP]2[/SUP]/m[SUP]2[/SUP]). Muscle mass correlated with both serum testosterone (tau = 0.132, p = 0.019) and MELD score (tau = −0.155, p = 0.007). In separate multivariable models, both sarcopenia (HR 1.05, p = 0.04) and low testosterone (HR 1.08, p = 0.01) were significantly associated with mortality independent of MELD score. When the variables MELD score, muscle area and testosterone were entered into a single model, low testosterone but not sarcopenia remained significantly predictive of mortality (HR 1.07, p = 0.02; HR 1.04, p = 0.09 respectively).</p><p></p><p></p><p>[h=4]Conclusion[/b]Low testosterone and sarcopenia are both associated with increased mortality in men with advanced liver disease and may identify patients at high risk of mortality that would be missed by the MELD score alone. Low testosterone appears to be a better predictor of mortality than sarcopenia and is a simpler test to improve the prognostic value of the MELD score. Interventional trials are required to determine whether low testosterone and sarcopenia are markers or mediators of mortality in this population. This article is protected by copyright. All rights reserved.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 25308, member: 3"] It is so disturbing for me to hear about men who are refused TRT because they have liver disease even though we know that T gels/creams, injections, pellets, etc do not cause liver issues (only old oral testosterone did). [B]Low testosterone is a better predictor of mortality than sarcopenia in men with advanced liver disease[/B] Journal of Gastroenterology and Hepatology, 2015 pp 1440-1746 [h=3]Abstract[/b][h=4]Introduction[/b]Both sarcopenia and low serum testosterone have been associated with increased mortality in men with cirrhosis. It is not known how these variables interact. [h=4]Methods[/b]We conducted a retrospective longitudinal cohort study of 145 men referred for liver transplant evaluation between 2005 and 2012. Baseline demographics included hormone profile and MELD score. Baseline computerised tomography was reformatted to calculate skeletal muscle area at L4 using validated, Tomovision software-based methodology. The primary outcome was time to death or liver transplantation. [h=4]Results[/b]Median testosterone was low at 6.2 nmol/L (ref 10–27.6 nmol/L) as was muscle mass at 48.0 cm[SUP]2[/SUP]/m[SUP]2[/SUP] (ref >52.4 cm[SUP]2[/SUP]/m[SUP]2[/SUP]). Muscle mass correlated with both serum testosterone (tau = 0.132, p = 0.019) and MELD score (tau = −0.155, p = 0.007). In separate multivariable models, both sarcopenia (HR 1.05, p = 0.04) and low testosterone (HR 1.08, p = 0.01) were significantly associated with mortality independent of MELD score. When the variables MELD score, muscle area and testosterone were entered into a single model, low testosterone but not sarcopenia remained significantly predictive of mortality (HR 1.07, p = 0.02; HR 1.04, p = 0.09 respectively). [h=4]Conclusion[/b]Low testosterone and sarcopenia are both associated with increased mortality in men with advanced liver disease and may identify patients at high risk of mortality that would be missed by the MELD score alone. Low testosterone appears to be a better predictor of mortality than sarcopenia and is a simpler test to improve the prognostic value of the MELD score. Interventional trials are required to determine whether low testosterone and sarcopenia are markers or mediators of mortality in this population. This article is protected by copyright. All rights reserved. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Low testosterone is a better predictor of mortality than sarcopenia in men with liver disease
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top